BLCO

SEC.gov | Request Rate Threshold Exceeded

U.S. Securities and Exchange Commission

You’ve Exceeded the SEC’s Traffic Limit

Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.

Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.

The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.

For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.

For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.

Reference ID: 0.e618d017.1785593537.3063e64c

More Information

Internet Security Policy

By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.

Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).

To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.

If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.

Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.

Note: We do not offer technical support for developing or debugging scripted downloading processes.

EX-99.1

2 ex991q1-2026.htm

EX-99.1

Document

Exhibit 99.1

Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook

•Revenue of $1.244 Billion

•Revenue Grew 9% as Reported and 6% on a Constant Currency1 Basis Compared to the First Quarter of 2025

•GAAP Net Loss Attributable to Bausch + Lomb Corporation of $71 Million

•Adjusted EBITDA (non-GAAP)1 of $189 Million; Adjusted EBITDA Excluding Acquired IPR&D (non-GAAP)1 of $200 Million

•Raising Full-Year 2026 Revenue and Adjusted EBITDA Excluding Acquired IPR&D (non-GAAP)1 Guidance

VAUGHAN, Ontario, April 29, 2026 – Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its first-quarter 2026 financial results.

“We’re doing exactly what we said we would: driving sustainable growth and margin expansion, improving how we sell and operate and continuing to invest in a pipeline that will carry us forward,” said

Brent Saunders, chairman and CEO, Bausch + Lomb.

Select Company Highlights

•Growth across key brands, including the dry eye portfolio, premium intraocular lenses and daily SiHy contact lenses

•Double-digit revenue growth in Pharmaceuticals led by MIEBO® (+33%) and XIIDRA® (+30%)

•PreserVision AREDS3™ and Blink Triple Care® Preservative Free U.S. launches underway, with nationwide distribution continuing to build

•Advanced R&D milestones with LUMIFY NXT™ NDA filed and seeLYRA™ CE submission completed

•Broad AI adoption helping drive operational efficiencies across the business

First-Quarter 2026 Revenue Performance

Total reported revenue was $1.244 billion for the first quarter of 2026, as compared to $1.137 billion in the first quarter of 2025, an increase of $107 million, or 9%. Excluding the favorable impact of foreign exchange of $42 million, revenue increased by approximately 6% on a constant currency1 basis compared to the first quarter of 2025.

1     This is a non-GAAP measure or a non-GAAP ratio. For further information on non-GAAP measures and non-GAAP ratios, please refer to the “Non-GAAP Information” section of this news release. Please also refer to tables at the end of this news release for a reconciliation of this and other non-GAAP measures to the most directly comparable GAAP measure.

1 | Page

Revenue by segment was as follows:

First-Quarter 2026

(in millions)Three Months Ended March 31 Change at Constant Currency1 (non-GAAP)

20262025Reported ChangeReported Change

Total Bausch + Lomb Revenue $1,244$1,137$1079 %6 %

Vision Care $711$656$558 %5 %

Surgical $228$214$147 %1 %

Pharmaceuticals $305$267$3814 %12 %

Vision Care Segment

Vision Care segment revenue was $711 million for the first quarter of 2026, as compared to $656 million for the first quarter of 2025, an increase of $55 million, or 8%. Excluding the favorable impact of foreign exchange of $25 million, segment revenue increased on a constant currency1 basis by approximately 5% compared to the first quarter of 2025. Performance was primarily driven by sales from over-the-counter dry eye products and LUMIFY® in the consumer business and growth of SiHy Daily lenses in the contact lens business.

Surgical Segment

Surgical segment revenue was $228 million for the first quarter of 2026, as compared to $214 million for the first quarter of 2025, an increase of $14 million, or 7%. Excluding the favorable impact of foreign exchange of $12 million, segment revenue increased on a constant currency1 basis by approximately 1% compared to the first quarter of 2025. Performance was primarily driven by growth in premium IOLs and consumables.

Pharmaceuticals Segment

Pharmaceuticals segment revenue was $305 million for the first quarter of 2026, as compared to $267 million for the first quarter of 2025, an increase of $38 million, or 14%. Excluding the favorable impact of foreign exchange of $5 million, segment revenue increased on a constant currency1 basis by approximately 12% compared to the first quarter of 2025. Performance was primarily driven by increased sales of MIEBO and XIIDRA and growth in International Pharmaceuticals.

Operating Results

Operating income was $33 million for the first quarter of 2026, as compared to an operating loss of $83 million for the first quarter of 2025, a favorable change of $116 million. The change was driven by the revenue performance noted above and operating efficiencies.

Net Loss

Net loss attributable to Bausch + Lomb Corporation for the first quarter of 2026 was $71 million, as compared to $212 million for the first quarter of 2025, a favorable change of $141 million. The change was primarily due to the increase in operating results noted above as well as a favorable change in the provision for income taxes.

Adjusted net income attributable to Bausch + Lomb Corporation (non-GAAP)1 for the first quarter of 2026 was $19 million, as compared t

blco-202602180001860742FALSEBausch & Lomb Corp00018607422026-02-182026-02-18

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 18, 2026 Date of Report (Date of the earliest event reported)

Bausch + Lomb Corporation (Exact Name of Registrant as Specified in Its Charter)

Canada 001-41380 98-1613662

(State or Other Jurisdiction of Incorporation or Organization) (Commission File Number) (I.R.S. Employer Identification Number)

520 Applewood Crescent Vaughan, Ontario Canada L4K 4B4 (Address of Principal Executive Offices)(Zip Code) (905) 695-7700 (Registrant’s telephone number, including area code) N/A (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered

Common Shares, No Par Value

BLCO

New York Stock Exchange Toronto Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition. On February 18, 2026, Bausch + Lomb Corporation (the “Company”) issued a press release announcing results of operations for the quarter and the year ended December 31, 2025 and certain other financial information as of and for the quarter and the year ended December 31, 2025. A copy of the press release is attached as Exhibit 99.1 to this report and is incorporated herein by this reference. The information in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 2.02 and Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended. Item 9.01. Financial Statements and Exhibits. (d)    Exhibits

Exhibit No.Description 99.1* Press Release of Bausch + Lomb Corporation, respecting financial results for the fourth quarter and full year ended December 31, 2025, dated February 18, 2026

104*Cover Page Interactive Data File (formatted as Inline XBRL)

* Filed herewith.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BAUSCH + LOMB CORPORATION

By:/s/ Sam Eldessouky

Name:Sam Eldessouky Title:Executive Vice President, Chief Financial Officer

Date: February 18, 2026